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1162-82 Diastolic Dysfunction in Elderly Patients Referred to the 
Heart Failure Diagnostic Clinic 
Nicolas Wisniacki. Pam Aimson, Chris Harrison, Michael Lye, University of Lnerpool, 
Liverpool, United Kingdom 
Background: Diastolic heart failure (DHF) accounts for a sianificant number of oatients 
with heart failure (HF) both in hospital settings and the community, and its proportion 
increases with aoe. HF diaanostic clinic (HFDC) have an imoortant role detectina cases 
of HF 1” the community. However, diastolic dysfunction (DD) has not been included as a 
cause of HF in several studies of HFDC. 
The objective of our study was to describe cardiac abnormalities associated with DHF in 
a group of elderly patients referred to a HFDC, and evaluates their association with the 
clinical diagnosis of HF. 
Methods: 130 elderly patients (a65 years old) referred to the HFDC within a 6 months 
period were included. Diagnosis of HF was made according to the Framingham criteria 
supported by pulmonary oedema on the chest X-ray. All patients’ underwent echocardio- 
graphic evaluation wth the operator unaware of the cllnical diagnosis. Results: 62 
patients (63.1%) had cllnical diagnosis of HF. Patients with clinical HF were more likely lo 
be diabetic (17.1% vs. 2.1% p=O.Ol), and have atrial fibrillation (13.4% vs. 0% p=O.O07) 
and left ventricular hypertrophy on the ECG (14.6% vs. 4.1% p=O.O5). Patients without 
clinical HF were more likely to have normal ECG (56.3% vs. 39% ~~0.05) and an 
obstructive pattern in the pulmonary function test (p=O.O3). Echocardiographic findings: 
Clinical HF 
(n=82) 
No clinical HF (n- p 
48) 
Ejection fraction (EF) ~40% 9 (11%) 0 0.02 
left ventricular hypertrophy 41 (50%) 16 (32.7%) 0.04 
left atrial enlargement 35 (43.2%) 5 (10.2%) 0.000 
1 
EIA ratio < 0.5 25 (30.9%) 12 (24.5%) 0.43 
Deceleration time >280 msec. 20 (24.7%) IO (20.4%) 0.57 
lsovolumic relaxation time > 105 msec 58 (71.6%) 24 (49%) 0.01 
EF >40% and> 2 parameters associated 50 (61%) 11 (22.9%) o.oM) 
with DD 1 
Conclusion: DD IS frequently found in elderly patients referred to a HFDC. The majority of 
patients with clinical diagnosis of HF have 2 or more abnormal parameters of DD. 
1162-83 Determinants of Left Atrial Volume and Dimension: A 
Prospective Study 
Teresa S. Tsang, Marion E. Barnes Kent R. Bailey, James B. Seward, Mayo Clinic, 
Rochester, MN 
Background: Left atrial (LA) enlargement occurs with advancing age and is associated 
with increased risk of atrial fibrillation (AF) and stroke. Clinical and subclinical determi- 
nants of LA size have not been well characterized. 
Methods: Consecutive patients referred for a clinically-indicated echocardiogram, who 
were, on the date of examination. ZO years of age, wlthout congenital heart disease, 
pacemaker, or prosthetic valves, and willing lo provide verbal consent, were included in 
this prospective study. &plane LA volume by the area-length method was measured pro- 
spectively, in additton to M-mode L4 dimension and other routine echocardlographic 
parameters. Demographic information and details of medical history were obtalned from 
clinical records. Linear and logistic regression models were developed to identify deter- 
minants of LA dimension and LA volume. 
Results: The study population consisted of 416 patients (232 men), mean age 71 * 8 
years. In a multivariate model, LA volume was associated with body surface area (BSA), 
hlstorv of AF. svstemlc hvoeflension. oeak mitral earlv fillina velxitv (a diastolic function _, _ I ,, 
parameter), lefi ventricular (LV) mass (all P<O.OOl), valvular heart disease greater than 
mild fP=O.O09). and conoestive heart failure fP=O.O071. LA volume was inverselv associ- 
ated with LV ejection fracbon (P=O.O34). Parameters for age and sex did not reach statis- 
tical significance once LA volume was adjusted for BSA. Similarly, M-mode LA 
dimension was Independently related lo history of AF, systemic hypertension, peak mitral 
early velocity, LV mass and ejection fraction. LA dimension was also strongly associated 
with age, sex, weight, and coronary artery disease. 
Conclusions: LA size is associated with history of AF, valvular disease, congestive 
heart failure, coronary artery disease, LV mass, and LV diastolic and systolic abnormali- 
ties. In contrast to the findings for LA dimension, the effect of age on LA volume did not 
reach statistical significance. Sex was also not a significant determinant of LA volume 
once BSA has been taken into account. 
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1162-84 Diastolic Left Ventricular Filling Patterns in Diastolic 
VSrSuS SyStOlic Congestive Heart Failure of the Elderly: 
The Cardiovascular Heart Study 
John S. Gottdiener, Gerard P. Aurigemma, Dalane W. Kitzman, Alice M. Arnold, Cheryl 
S. Egher, Karen M. Fowls, Jeffrey C. Hill, St. Francis Hospital, Roslyn, NY, National 
Heart, Lung, and Blood Institute, Bethesda, MD 
Lefi ventricular (LV) diastolic filling patterns based on peak early (E) and late (A) filling 
velocity on echo are well described in congestive heart failure (CHF) usually in patients 
with decreased ejection fraction (EF) (sysHF). However, in elderly with CHF, LV EF is 
often normal (2 55%) i.e diastolic HF (diasHF). The Cardiovascular (CV) Health Study 
(HS) is a prospective community based study of risk factors for CV disease (D) in 5,888 
elderly participants (ppts). We analyzed LV filling in a nested case control study of 182 
ppts (av age 79 + 6, range 68-99, 47% women) with CHF evaluation in 1994.5, of whom 
174 had complete echo data. Case controls were 417 ppts without CHF (54% with sub- 
clinical CVD, 19% with prevalent CVD) matched to age and gender. Filling pattern defini- 
tions: “normal” = 0.8-I .5 and normal LA volume (determined from 2D echo in healthy 
participants using ellipsoid model); “impaired relaxation” = VA 1.8. Gender distribution 
was: controls (n=417), men 45%; dia.sHF (n=95), men 42%; sysHF(n=87), men 63% (pc 
,004 diasHF vs sysHF). Conclusions: DiaHF in elderly is more common in women. 
SysHF, is more common in men. There are gender differences between filling patterns in 
population controls and sysHF, but not diasHF. SysHF and diasHF are associated mostly 
with impaired relaxation and pseudonormal patterns of LV filling. CHF is uncommon in 
the presence of normal filling. However, abnormal filling is common in the absence of 
CHF 
Filling Pattern 
Normal 
Impaired relaxation 
Controls 
12 (32%) 
165 (49%) 
Diastolic HF 
6 (9%) 
33 (47%) 
Systolic HF 
1 (2%) 
1 (46%) 
Pseudonormal 
Restrictive 
25 (35%) 16 65 (17%) (27%) 
10 (2%) 17 
6 (9%) 
(25%) 
(pc.001 dias HF vs controls; p =.019 diastolic HF vs systolic HF) 
1162-85 Plasma Levels of Inflammatory C-Reactive Protein and 
Interleukin-6 Predict Outcome in Elderly Patients With 
Stroke 
Antonello Silvestri, Mauricio Wajngatlen, Crlstiana Vitale, Otavio Gebara, Massimo Fini, 
Jo& Antonio F. Ramires. Giuseooe M. Rosano, San Raffaele, Roma, Italy, INCOR, Sao 
Paula, Brazil 
C-Reactive protein (CRP) is associate with unfavorable outcome in patients with acute 
ischemic syndromes and in patients with chronic stable angina. Elevated CRP levels 
suggestive of heightened Inflammatory state in vascular conditions are often associated 
with elevated Interleukin-6 (IL-6) levels. The predictive importance of CRP and IL-6 lev- 
els in patients with ischemic stroke has never been elucidated. To this end we studied 
among 647 consecutive elderly patients (>65 years) those with documented ischaemic 
stroke, presence of significant carotid atherosclerosis and absence of atrial fibrillation. 
The study population included 150 patients (74 men, 76 women mean age 74+2) 
Patients underwent evaluation of high senibve CRP and IL-6 levels at baseline, during 
hospitalization and at discharge. In-hospital was 6%, 1 year mortality was 15% and 
another cerebrovascular event occurred in 12% of patients. Patients with in-hospital 
events had significantly higher CRP and IL-6 levels than patients wIthout events (3.el.l 
vs i.9fl.9 mg/l. p-zO.01 and 13.8fi.4 vs 6.3t2.1 pgiml, p<O.Ol, respectively). Also CRP 
and IL-6 levels were significantly higher in those pabents with an event within 3 months of 
discharge compared to those patients without an event (3.6kl.3 vs 1 .I$.7 mgll, p<O.Ol 
and 14.223.7 vs 5.4il.6 pg/ml, p<O.Oi, respectively). Both baseline CRP levels and IL-6 
were predictor of future in-hospital and 3 months future cerebrovascular events while 
high CRP and IL-6 levels at baseline were not associated with a poor 1 year prognosis. 
Elevated CRP levels were associated with an unfavorable outcome only when IL-6 levels 
were also elevated. In a stepwise multivariate analysis IL-6 levels were stronger predictor 
of outcome than CRP. 
In conclusion elevated CRP and IL-6 levels may identify elderly patients at increased 
medium term risk while do not predict one year events in this subset of patients. CRP lev- 
els predict events only when they are coupled with IL-6 levels. 
1162-86 Is Enhanced External Counterpulsation the Preferred 
Treatment for Chronic Stable Angina in Select Patients 
75 Years and Older? 
Georgiann C. Linnemeier, Elizabeth D. Kennard, Sheryl F. Kelsey, Ozlem Soran, 
University of Pittsburgh, Pittsburgh, PA 
Background: Elderly patients are at high risk for morbidity and mortality associated with 
invasive coronary interventions. Enhanced external counterpulsation (EECP) has been 
demonstrated to be safe and effective in treating angina in patients 275 years of age; 
however, its effect on long-term cardiac event-free survival is unknown. 
Methods: Of 1552 patients consecutively enrolled in the International EECP Patient 
Reglstiy, 347 were 275 years (E) and 1205 were ~75 years (Y).EECP was adminlstered 
to each group with similar total treatment hours and completion rates. 
Results: E differed significantly from Y in history of symptomatic congestive heart failure 
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(41% vs 32%, pcO.01) and non-cardvx vascular disease (38% vs 26%, pcO.001). There 
was no difference between the groups in gender, angina severity, or ejection fraction 
(46%). At completion of treatment most patients, young and old, had angina reduction of 
_> 1 Canadian Cardiovascular Society class with angina episodes and nitoglycerin use 
significantly reduced as well. At one year, 81% reported maintenance of symptom 
improvement and major adverse cardiac event-free survival was comparable in both 
groups (P&86). 
Conclusion: Patients seek medical care to live longer or feel better. EECP offers elderly 
patients, even those with extensive cardiovascular disease, a low-risk intervention that 
significantly reduces angina1 symptoms with cardiac event-free survival comparable to 
younger patients with similar symptoms. 
1162-87 Coronary Interventions in 1,070 Consecutive 
Octogenarians: Complication Rates in Diabetic Versus 
Nondiabetic Patients 
Josef Niebauer, Sebastian Sixt, Fuchun Zhang, Jiangtao Yu. Peter Sick, Holger Thiele. 
Bernward Lauer, Gerhard Schuler. Heart Center University of Leipzig, Leipzig, 
Germany 
Background: Octogenarians with Diabetes mellitus type 2 are perceived as a high risk 
population for procedure-related complications. Since only few studies reported compli- 
cation rates in this population in the era of coronary stenting, we set out to assess their 
risk in a large cohort of patients. 
Methods: We studied 1070 consecutive patients >80 years (82.622.6 year?.; 526 males, 
544 females; 396 with Diabetes (DM). 674 without Diabetes (Non-DM)),who underwent 
cardiac catheterization between January 1995 and July 2000. 
Results: Age (DM: 82.4e2.4 vs. Non-DM: 82.8i2.8 years; p=n.s.) and number of acute 
myocardial infarctions (MI) (DM: 27%, Non-DM: 23%; p=n.s.) were similar in both groups. 
There were more women in the DM (57 %) than in the Non-DM group (44 %; p<O.OOl). 
Diabetics had more 3-vessel disease (DM: 35% vs Non-DM: 29%; ~~0.02); there were 
significantly rnme balloon angioplasties performed in non-diabetic patients (DM: 27% vs 
Non-DM: 43%; pcO.OOl), whereas a higher, but non-significant number of diabetic 
patients underwent bypass surgery (DM: 36% vs Non-DM: 30%; p=O.16). A total of 32 
patients (3%) died (DM: n=6; non-DM: n=26): 5 deaths occured during procedures (3 
patients died during rescue PTCA, 2 during emergency surgery), 16 patients were 
already admitted in cardiogenic shock, 6 died due to complications associated with acute 
myocardial infarctions (e.g. ventricular septal defect), 2 due to decompensated aortic 
stenoses, 2 patrents due to pulmonary embolism, 1 due to aortic dissection type A. At the 
puncture site 39 complications occured (DM 3% vs. non-DM 4%, p=n.s.) 
Conclusions: Despite the notion that it is the diabetic patients among the octogenarians 
who have the highest complication rates, this study shows in a large cohort of patients 
that their complication rates are well comparable to non-diabetic patients, and would thus 
not warrant a more conservative treatment strategy in these patients. 
1162-88 High Endogenous Estrogen Levels Are Predictive of 
Increased Carotid Intimal: Medial Thickness in Elderly 
Postmenopausal Women 
Barlv Ii. McKeown, Richard L. Prince, Amanda Devine, John P. Bellby, Brendan M. 
McQuillan, Joseph Hung, Peter L. Thompson, The Heart Research Institute Sir Charles 
Gairdner Hospital, Perth, Australia, The Unwers~ty of Western Australia Perth, Australia 
Background Little IS known about the relationship between endogenous estrogen and 
atherosclerosis in postmenopausal women. We have examined the association between 
estrogen levels and carotid intimal-medlal thickness (IMT) in a population-based cohort 
study of elderly women who were not taking oral estrogen replacement (Calcium Intake 
fracture Outcome Study - CAIFOS). Methods We assessed 1130 CAIFOS subjects aged 
75.2 +I- 2.7 years (mean+/-standard deviation) at baseline for cardiovascular risk factors 
and estrogen levels and at one year for plasma homocysteine and glycated haemoglo- 
bin. Free Estradiol Index (FE1 - molar ratio of plasma estradiol to sex hormone binding 
globulin x 1000) was used as the measure of endogenous estrogen Three years after 
baseline these wcvnen were assessed for carotid IMT using bilateral carotid B-mode 
ultrasound. Results At baseline 12.2% of these subjects had a history of cardiovascular 
disease (Ischaemic hear? disease, peripheral vascular disease or stroke). Women wth 
greater than the median level of FEI (47.0) had increased mean IMT compared to those 
wth lower levels (0.79mm vs 0.77mm, p=O.O07) The following factors also had a pow 
tive univariate association with IMT; age(p<O.OOOi), pulse pressure (p<O.OOOl). body 
mass index (p=O.Ol), a history of smoking (p=O.Ol) and glycated haemoglobln (p=O.O4). 
In multivariate analysis, the following variables were independently predictive of 
increased IMT; increased pulse pressure (p<O.OOOl). increased age (pcO.OOOl), a his- 
tory of smoking (p=O.O03) and increased FEI (a level greater than the median p=O.O08). 
Conclusion Our study shows that an increased level of endogenous estrogen is predic- 
tive of carotid atherosclerosis and may therefore be important in increasing atheroscle- 
rotic risk in postmenopausal women. 
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844-1 BetaP-Adrenergic Receptor Polymorphisms Predict 
Heart Failure Progression in Idiopathic Dilated 
Cardiomyopathy 
Cinzia Forleo, Nicolena Resta, Sandra Sorrentino, Pi&o Guida, Andrea Manghisi, 
Viviana De Luca, Roberta Romito, Massimo lacoviello, Francesco Massari, Brian Rizzon, 
Ginevra Guanti, Paolo Riuon. Mariavittoria Pitzalis, Bari, Italy 
Background. The stimulation of P2-adrenergic receptor @P-AR) plays a crucial role in 
maintaining catecholamine-mediated inotropism in idiopathic dilated cardiomyopathy 
(DCM). Therefore, P-AR polymorphic variants could influence prognosis in patients with 
DCM. 
Patients and MethodsTo test this hypothesis, we prospectively analysed 160 consecu- 
tive unrelated patients (mean age 49+14 years, 121 males) with DCM (WHO criteria), 
while receiving optimal treatment. All the patients were characterised for the 5’ leader cis- 
tron (SLC)-ArglSCys, ArglGGly, Gln27Glu, and Thrl64lle polymorphisms of the P-AR 
on the basis of PCR amplified DNA using RFLP or SSCP analysis. The progression 
towards HF (worsening in clinical conditions leading to one of the following events: hospi- 
talisation, cardiac transplantation, death) was considered as end point. 
Results. After a median follow-up of 18 months, 11 patients were hospitaksed for con- 
gestive HF, three underwent cardiac transplantation and seven died. Kaplan-Meier sur- 
vival cwves showed that the 5’LC-Arg19/Glu27 haplotype was significantly related to 
events (~~0.05, figure). By Cox multivariate analysis, the 5’LC-Arg19/Glu27 haplotype 
was associated with HF progression (RR=4.09, p<O.Ol), also after adjustment for age, 
NYHA functional class, and left ventricular ejection fraction (RR=4.05, p=O.Oi). 
Conclusions. Among DCM patients, those showing the SLC-Arg19iGlu27 haplotype of 
the@-AR show the worst progresslon of HF at 18 months of follow-up. 
10:45 a.m. 
844-2 Circulating Tumor Necrosis Factor-Alpha and Matrix 
Metalloproteinase Activities in Patients With Idiopathic 
Dilated Cardiomyopathy: Effects of Beta-Blocker on 
Cardiac Matrix Remodeling 
Tomoaki Ohtsuka Mareomi Hamada, Yuji Shigematsu, Yuji Hara, Akiyoshi Ogimoto, 
Tsuyoshi Matsunaka, Jun Suzuki, Katsuji Inoue, Kiyotaka Ohshima, Norikatsu Morioka, 
Akira Kurata, Jitsuo Higaki, Ehime University School of Medicine, Ehime, Japan 
Background: Matrix metalloproteinases (MMPs) contribute to myocardial matrix degrada- 
tion during the remodeling process in the failing heart. Recently, increased myocardial 
MMP activity has been reported to occur in clinical forms of dilated cardiomyopathy. 
Tumor necrosis factor (TNF)-alpha is an important regulator of MMP gene expression. 
This study was designed to clarify the relationship between circulating TNF-alpha and 
MMP activities in patients with idiopathic dilated cardiomyopathy (IDC) and to evaluate 
the effect of beta-blocker on circulating MMP activity in IDC. Methods: We studied 34 
patients with IDC and 10 healthy control subjects. Serum levels of TNF-alpha, MMP-I, 
MMP-3 and MMP-9 were measured using enzyme-linked lmmunosorbent assay. Plasma 
levels of norepinephrine and brain natriuretic peptide (BNP) were also measured. In 20 
patients who had been treated with angiotensin II type 1 receptor blockers, carvedilol 
was administered an addition to the combination therapy. Results: Serum levels of TNF- 
alpha, MMP-1, MMP-3 and MMP-9 were significantly higher in all patients with IDC than 
in control subjects (PC 0.05 for all). There was a significant positive correlation between 
TNF-alpha and MMP-9 levels (r= 0.764, P= 0 01). The MMP-9 levels were also positively 
correlated wth norepinephrine levels (r= 0.750, P= 0.005). In addition, there was a posi- 
tlve correlation between MMP-1 and BNP levels (I= 0.647, P= 0.022) In patients treated 
with carvedilol, the high levels of MMP-1, MMP-9 and TNF-alpha were significantly 
decreased during the treatment (PC 0.05 for all), although MMP-3 levels remained 
unchanged. Conclusion: Circulating TNF-alpha is closely related to MMP activity in IDC 
